Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T91959 | Target Info | |||
Target Name | NAD-dependent deacetylase sirtuin-3 (SIRT3) | ||||
Synonyms | hSIRT3; SIR2L3; SIR2-like protein 3; Regulatory protein SIR2 homolog 3 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | SIRT3 | ||||
Biochemical Class | Sirtuin family. Class I subfamily | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Carba-Nicotinamide-Adenine-Dinucleotide | Ligand Info | |||
Canonical SMILES | C1C(C(C(C1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O | ||||
InChI | 1S/C22H29N7O13P2/c23-19-14-21(26-8-25-19)29(9-27-14)22-18(33)17(32)13(41-22)7-40-44(37,38)42-43(35,36)39-6-11-4-12(16(31)15(11)30)28-3-1-2-10(5-28)20(24)34/h1-3,5,8-9,11-13,15-18,22,30-33H,4,6-7H2,(H5-,23,24,25,26,34,35,36,37,38)/p+1/t11-,12-,13-,15-,16+,17-,18-,22-/m1/s1 | ||||
InChIKey | DGPLSUKWXXSBCU-VGXGLJSLSA-O | ||||
PubChem Compound ID | 163884 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4BN5 Structure of human SIRT3 in complex with SRT1720 inhibitor | ||||||
Method | X-ray diffraction | Resolution | 3.25 Å | Mutation | No | [1] |
PDB Sequence |
KLSLQDVAEL
131 IRARACQRVV141 VMVGAGISTP151 SGIPDFRSPG161 SGLYSNLQQY171 DLPYPEAIFE 181 LPFFFHNPKP191 FFTLAKELYP201 GNYKPNVTHY211 FLRLLHDKGL221 LLRLYTQNID 231 GLERVSGIPA241 SKLVEAHGTF251 ASATCTVCQR261 PFPGEDIRAD271 VMADRVPRCP 281 VCTGVVKPDI291 VFFGEPLPQR301 FLLHVVDFPM311 ADLLLILGTS321 LEVEPFASLT 331 EAVRSSVPRL341 LINRDLVGPL351 AWHPRSRDVA361 QLGDVVHGVE371 SLVELLGWTE 381 EMRDLVQRET391 GKL
|
|||||
|
GLY145
3.777
ALA146
3.137
GLY147
3.473
SER149
3.653
THR150
3.464
PRO151
4.205
ILE154
3.176
ASP156
3.607
ARG158
3.164
LEU199
4.923
GLN228
2.966
ASN229
3.402
ILE230
2.998
ASP231
2.448
|
|||||
PDB ID: 4FVT Human SIRT3 bound to Ac-ACS peptide and Carba-NAD | ||||||
Method | X-ray diffraction | Resolution | 2.47 Å | Mutation | No | [2] |
PDB Sequence |
KLSLQDVAEL
131 IRARACQRVV141 VMVGAGISTP151 SGIPDFRSPG161 SGLYSNLQQY171 DLPYPEAIFE 181 LPFFFHNPKP191 FFTLAKELYP201 GNYKPNVTHY211 FLRLLHDKGL221 LLRLYTQNID 231 GLERVSGIPA241 SKLVEAHGTF251 ASATCTVCQR261 PFPGEDIRAD271 VMADRVPRCP 281 VCTGVVKPDI291 VFFGEPLPQR301 FLLHVVDFPM311 ADLLLILGTS321 LEVEPFASLT 331 EAVRSSVPRL341 LINRDLVGPL351 AWHPRSRDVA361 QLGDVVHGVE371 SLVELLGWTE 381 EMRDLVQRET391 GKLD
|
|||||
|
GLY145
3.295
ALA146
2.885
GLY147
3.390
SER149
4.248
THR150
2.995
PRO151
4.235
ILE154
3.973
PRO155
3.483
ASP156
3.592
PHE157
3.153
PHE180
3.927
LEU199
4.902
GLN228
3.471
ASN229
3.286
ILE230
2.612
ASP231
3.052
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structures of human sirtuin 3 complexes with ADP-ribose and with carba-NAD+ and SRT1720: binding details and inhibition mechanism. Acta Crystallogr D Biol Crystallogr. 2013 Aug;69(Pt 8):1423-32. | ||||
REF 2 | Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5. J Org Chem. 2012 Sep 7;77(17):7319-29. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.